Amryt Pharma PLC (AMYT) Stock Rating Reaffirmed by Beaufort Securities
Amryt Pharma PLC (LON:AMYT)‘s stock had its “speculative buy” rating reissued by Beaufort Securities in a research report issued to clients and investors on Tuesday.
Separately, Shore Capital reissued a “house stock” rating on shares of Amryt Pharma PLC in a report on Thursday, June 9th.
Amryt Pharma PLC (LON:AMYT) opened at 18.88 on Tuesday. The company’s 50 day moving average is GBX 18.96 and its 200 day moving average is GBX 19.01. Amryt Pharma PLC has a 52-week low of GBX 14.00 and a 52-week high of GBX 31.20. The firm’s market cap is GBX 39.33 million.
Receive News & Ratings for Amryt Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.